| |
Normal weight (BMI18- < 25 kg/m2)
|
Obese (BMI > 35 kg/m2)
|
Odds ratio (95% CI)
|
P
|
|---|
|
Number (n)
|
389
|
204
|
–
|
–
|
|
Age (mean years ± SD)
|
67 ± 9
|
68 ± 9
|
–
|
0.20
|
|
Hypertension (n)
|
84
|
119
|
5.08 (3.53–7.30)
|
< 0.0001
|
|
Dyslipidaemia (n)
|
42
|
64
|
3.78 (2.44–5.84)
|
< 0.0001
|
|
Atrial fibrillation (n)
|
24
|
29
|
2.52 (1.46–4.48)
|
0.0021
|
|
Ventricular arrhythmia (n)
|
5
|
1
|
0.38 (0.032–2.76)
|
0.67
|
|
Diabetes (n)
|
15
|
67
|
12.19 (6.71–22.19)
|
< 0.0001
|
|
Stroke (n)
|
6
|
5
|
1.60 (0.55–5.47)
|
0.52
|
|
Angina (n)
|
20
|
38
|
4.22 (2.40–7.38)
|
< 0.0001
|
- Amongst those testing positive for Covid-19, participants with BMI > 35 kg/m2 (obese II) have greater odds ratios for hypertension, dyslipidaemia, atrial fibrillation, diabetes and angina than individuals with normal weight (BMI 18.5 to < 25.0 kg/m2). There were no differences between groups for stroke and ventricular arrhythmia. T test was used to test for differences in age between groups, and Fisher’s exact test for categorical variables
